COMP <GO>
NATR vs MRK // OPERATING MARGIN
Nature's Sunshine Products Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: NATR 6
— MRK 7
▲ OPERATING MARGIN LEADER: MRK
LAST: $12.02 (-1.88%) • MKT CAP: $211.5M
operating-margins
5.20%
LAST: $148.36 (-0.78%) • MKT CAP: $366.03B
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NATR VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NATR | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 72.40% | 74.80% | -2.40 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.90% | 20.70% | +8.20 | NATR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.0x | 15.3x | -11.30 | NATR | /valuation <GO> |
| Free Cash Flow Yield | 13.35% | 3.42% | +9.93 | NATR | /fcf-yield <GO> |
| Operating Margin ACTIVE | 5.20% | 34.30% | -29.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 4.10% | 28.10% | -24.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 1.30% | +4.40 | NATR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.33 | 5.19 | -0.86 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | NATR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.7 | 54.3 | -20.60 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | 18.4x | -8.10 | NATR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $211.5M | $366.03B | -$365.82B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NATR REV | MRK REV | NATR GROSS % | MRK GROSS % | NATR FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $480.1M | $65.01B | 72.4% | 74.8% | $28.8M | $12.36B |
| FY 2024 | $454.4M | $64.17B | 71.5% | 76.3% | $14.3M | $18.10B |
| FY 2023 | $445.3M | $60.12B | — | — | $41.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NATR // BETA —
MRK // BETA 0.92